USPTO trademark

CENCORA ADVANCED THERAPIES PHARMACY

Under examinationUSPTOWord markClass 35

"CENCORA ADVANCED THERAPIES PHARMACY" is a word mark owned by Cencora, Inc., filed at the USPTO on September 10, 2026. It is under examination and covers class 35 (Advertising and Business).

View Cencora, Inc. portfolioGet this data via the API
Official USPTO record
CENCORA ADVANCED THERAPIES PHARMACY trademark as filed
As filed with the USPTO
Status
Under examination
Since September 10, 2026
Filed
September 10, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50100129
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns CENCORA ADVANCED THERAPIES PHARMACY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Cencora, Inc.

COR · Conshohocken, United States

117 trademarks in the portfolioView company

Representative

Anita B. Polott

Morgan, Lewis & Bockius LLP

Goods and services

What the mark covers

The products and services CENCORA ADVANCED THERAPIES PHARMACY is filed for, grouped by Nice class.

  • Specialized retail pharmacy services for patients with particular medical conditions; Mail order pharmacy services; Distributorship services in the field of specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients; Wholesale ordering services in the field of specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About CENCORA ADVANCED THERAPIES PHARMACY

Who owns the trademark "CENCORA ADVANCED THERAPIES PHARMACY"?

The USPTO trademark "CENCORA ADVANCED THERAPIES PHARMACY" (application 50100129) is owned by Cencora, Inc.

What is the status of "CENCORA ADVANCED THERAPIES PHARMACY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CENCORA ADVANCED THERAPIES PHARMACY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a09097-584d-73b0-b113-67111464347f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a09097-584d-73b0-b113-67111464347f",
  "object": "trademark",
  "mark_text": "CENCORA ADVANCED THERAPIES PHARMACY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50100129",
  "filing_date": "2026-09-10",
  "nice_classes": [
    35
  ],
  "owners": [
    {
      "name": "CENCORA, INC.",
      "entity_id": "ent_019ebbf1-fb37-770a-88c0-e6dfb29d2c05"
    }
  ]
}